Credit Suisse’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$50.6M Sell
451,896
-30,860
-6% -$3.33M 0.05% 366
2023
Q4
$48.7M Buy
482,756
+745
+0.2% +$73.9K 0.05% 396
2023
Q3
$41.8M Sell
482,011
-17,216
-3% -$1.56M 0.04% 432
2023
Q2
$47.2M Sell
499,227
-149,618
-23% -$12.6M 0.05% 421
2023
Q1
$49M Buy
648,845
+29,164
+5% +$2.2M 0.05% 406
2022
Q4
$47.6M Sell
619,681
-234,322
-27% -$17.8M 0.05% 412
2022
Q3
$56.9M Buy
854,003
+384,103
+82% +$24.3M 0.06% 329
2022
Q2
$24.6M Sell
469,900
-154,291
-25% -$8.77M 0.03% 622
2022
Q1
$35.4M Buy
624,191
+145,485
+30% +$7.79M 0.03% 574
2021
Q4
$24.6M Sell
478,706
-124,692
-21% -$6.12M 0.01% 986
2021
Q3
$29.8M Sell
603,398
-128,190
-18% -$6.95M 0.02% 887
2021
Q2
$42M Buy
731,588
+60,451
+9% +$3.53M 0.02% 777
2021
Q1
$40.8M Sell
671,137
-8,405
-1% -$464K 0.02% 794
2020
Q4
$36.4M Sell
679,542
-114,355
-14% -$5.93M 0.02% 846
2020
Q3
$37.3M Sell
793,897
-66,974
-8% -$3.44M 0.02% 730
2020
Q2
$44.9M Buy
860,871
+154,146
+22% +$7.95M 0.03% 580
2020
Q1
$33.9M Buy
706,725
+46,638
+7% +$2.42M 0.03% 577
2019
Q4
$33.4M Buy
660,087
+128,251
+24% +$6.62M 0.02% 748
2019
Q3
$25.1M Sell
531,836
-56,268
-10% -$2.57M 0.02% 783
2019
Q2
$27.7M Buy
588,104
+128,405
+28% +$5.92M 0.02% 729
2019
Q1
$22.1M Buy
459,699
+49,105
+12% +$2.46M 0.02% 809
2018
Q4
$18.3M Sell
410,594
-6,614
-2% -$345K 0.02% 837
2018
Q3
$22.5M Buy
417,208
+30,224
+8% +$1.55M 0.02% 803
2018
Q2
$18.9M Sell
386,984
-18,412
-5% -$1.04M 0.02% 873
2018
Q1
$25.4M Sell
405,396
-96,738
-19% -$6.64M 0.02% 730
2017
Q4
$30.8M Buy
502,134
+26,477
+6% +$1.64M 0.03% 643
2017
Q3
$31.8M Sell
475,657
-79,016
-14% -$5.59M 0.03% 595
2017
Q2
$43.2M Sell
554,673
-147,387
-21% -$11.1M 0.04% 453
2017
Q1
$57.3M Sell
702,060
-17,772
-2% -$1.4M 0.05% 386
2016
Q4
$51.8M Sell
719,832
-66,787
-8% -$4.83M 0.05% 389
2016
Q3
$61.1M Sell
786,619
-43,017
-5% -$3.48M 0.06% 353
2016
Q2
$64.7M Buy
829,636
+57,966
+8% +$4.62M 0.07% 272
2016
Q1
$63.2M Sell
771,670
-20,416
-3% -$1.66M 0.08% 271
2015
Q4
$70.7M Sell
792,086
-232,668
-23% -$19.8M 0.08% 255
2015
Q3
$78.7M Sell
1,024,754
-138,736
-12% -$11.6M 0.09% 223
2015
Q2
$97.3M Buy
1,163,490
+28,418
+3% +$2.51M 0.09% 223
2015
Q1
$102M Sell
1,135,072
-73,477
-6% -$6.33M 0.1% 202
2014
Q4
$97.6M Buy
1,208,549
+253,115
+26% +$20M 0.09% 226
2014
Q3
$71.6M Sell
955,434
-112,342
-11% -$8.17M 0.06% 352
2014
Q2
$73.2M Buy
1,067,776
+104,984
+11% +$7.15M 0.06% 336
2014
Q1
$67.4M Buy
962,792
+2,403
+0.3% +$167K 0.07% 304
2013
Q4
$64.2M Buy
960,389
+178,508
+23% +$10.9M 0.06% 321
2013
Q3
$40.8M Sell
781,881
-203,870
-21% -$10.4M 0.04% 435
2013
Q2
$46.5M Buy
+985,751
New +$45M 0.05% 398

Other funds holding CAH

Credit Suisse's CAH Position: Q1 2024 in Review

Credit Suisse reduced its Cardinal Health (CAH) stake by 6.4% in Q1 2024, selling an estimated $3.33M and leaving 451,896 shares worth $50.6M. The position accounts for 0.05% of the portfolio, ranked #366.

Credit Suisse first reported a position in CAH in Q2 2013 and has held it in 44 quarters since. The position peaked at $102M in Q1 2015. 1,057 funds tracked by Wall St. Rank hold CAH as of Q1 2024.

  • Credit Suisse held 451,896 shares of Cardinal Health worth $50.6M as of Q1 2024.
  • Credit Suisse sold 30,860 Cardinal Health shares in Q1 2024, an estimated $3.33M.
  • Cardinal Health made up 0.05% of Credit Suisse's portfolio in Q1 2024, its #366 holding.
  • Credit Suisse first reported a position in Cardinal Health in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Cardinal Health position peaked at $102M in Q1 2015.
  • 1,057 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.